Geoff Meacham
Stock Analyst at Citigroup
(3.67)
# 748
Out of 4,869 analysts
252
Total ratings
54.72%
Success rate
4.08%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics | Initiates: Buy | $72 | $53.34 | +34.98% | 1 | Jun 17, 2025 | |
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $42 | $17.96 | +133.85% | 1 | Jun 17, 2025 | |
| ACLX Arcellx | Initiates: Buy | $110 | $63.00 | +74.60% | 1 | Jun 17, 2025 | |
| AMLX Amylyx Pharmaceuticals | Initiates: Buy | $12 | $5.05 | +137.62% | 2 | Jun 17, 2025 | |
| ABOS Acumen Pharmaceuticals | Initiates: Buy | $4 | $1.20 | +233.33% | 4 | Jun 17, 2025 | |
| NVAX Novavax | Initiates: Sell | $6 | $6.41 | -6.40% | 1 | Jun 17, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $70 → $75 | $29.31 | +155.89% | 6 | Jun 10, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $700 → $650 | $509.72 | +27.52% | 22 | Jun 2, 2025 | |
| ABBV AbbVie | Downgrades: Neutral | $210 → $205 | $185.30 | +10.63% | 17 | May 14, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Neutral | $47 → $44 | $45.87 | -4.08% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $50 → $40 | $50.20 | -20.32% | 8 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $140 | $106.53 | +31.42% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $7 → $1 | $0.79 | +27.28% | 3 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $40 | $25.90 | +54.44% | 10 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $28.46 | +40.55% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $41.96 | +126.41% | 2 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $10.08 | +148.02% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $103 | $55.00 | +87.27% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $160 → $145 | $127.04 | +14.14% | 14 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $310 → $295 | $289.33 | +1.96% | 11 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $85 | $44.25 | +92.09% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $1.60 | +150.00% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $45 | $41.73 | +7.84% | 5 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $108.50 | +15.21% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $575 | $440.87 | +30.42% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $762.73 | +44.22% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $120 → $20 | $8.69 | +130.15% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $9.23 | +235.86% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $0.37 | +2,568.80% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $79.06 | +83.41% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $149.79 | +13.49% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $38 | $34.87 | +8.98% | 2 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $23.60 | +103.39% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $46.86 | +28.04% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 | $1.17 | +583.76% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $23 → $14 | $5.23 | +167.69% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $5.44 | +47.19% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $0.50 | +3,296.60% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $23.97 | +87.73% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $1.96 | +1,124.49% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $3.21 | +24.61% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.37 | +1,943.80% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.58 | +5,742.93% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $4.41 | +1,169.84% | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $1.07 | +3,171.03% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $3.37 | +15,478.64% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $1.09 | +3,753.21% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $6.34 | +215.46% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.46 | +4,271.58% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $3.20 | +181.69% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $8.43 | +611.74% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $3.93 | +78.12% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $12.48 | +84.29% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $68.46 | +19.78% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $290.75 | -67.33% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $9.40 | +751.06% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $126.55 | +6.68% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $5.72 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $0.70 | +2,750.63% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $14.46 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $309.70 | -48.98% | 5 | Nov 8, 2017 |
Protagonist Therapeutics
Jun 17, 2025
Initiates: Buy
Price Target: $72
Current: $53.34
Upside: +34.98%
NewAmsterdam Pharma Company
Jun 17, 2025
Initiates: Buy
Price Target: $42
Current: $17.96
Upside: +133.85%
Arcellx
Jun 17, 2025
Initiates: Buy
Price Target: $110
Current: $63.00
Upside: +74.60%
Amylyx Pharmaceuticals
Jun 17, 2025
Initiates: Buy
Price Target: $12
Current: $5.05
Upside: +137.62%
Acumen Pharmaceuticals
Jun 17, 2025
Initiates: Buy
Price Target: $4
Current: $1.20
Upside: +233.33%
Novavax
Jun 17, 2025
Initiates: Sell
Price Target: $6
Current: $6.41
Upside: -6.40%
Avidity Biosciences
Jun 10, 2025
Maintains: Buy
Price Target: $70 → $75
Current: $29.31
Upside: +155.89%
Regeneron Pharmaceuticals
Jun 2, 2025
Maintains: Buy
Price Target: $700 → $650
Current: $509.72
Upside: +27.52%
AbbVie
May 14, 2025
Downgrades: Neutral
Price Target: $210 → $205
Current: $185.30
Upside: +10.63%
Kymera Therapeutics
May 12, 2025
Maintains: Neutral
Price Target: $47 → $44
Current: $45.87
Upside: -4.08%
May 7, 2025
Upgrades: Neutral
Price Target: $50 → $40
Current: $50.20
Upside: -20.32%
May 6, 2025
Maintains: Buy
Price Target: $145 → $140
Current: $106.53
Upside: +31.42%
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $0.79
Upside: +27.28%
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $25.90
Upside: +54.44%
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $28.46
Upside: +40.55%
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $41.96
Upside: +126.41%
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $10.08
Upside: +148.02%
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $55.00
Upside: +87.27%
Feb 13, 2025
Maintains: Neutral
Price Target: $160 → $145
Current: $127.04
Upside: +14.14%
Jan 28, 2025
Maintains: Neutral
Price Target: $310 → $295
Current: $289.33
Upside: +1.96%
Jan 7, 2025
Maintains: Buy
Price Target: $98 → $85
Current: $44.25
Upside: +92.09%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $1.60
Upside: +150.00%
Nov 25, 2024
Maintains: Buy
Price Target: $42 → $45
Current: $41.73
Upside: +7.84%
Nov 14, 2024
Initiates: Buy
Price Target: $125
Current: $108.50
Upside: +15.21%
Nov 14, 2024
Initiates: Buy
Price Target: $575
Current: $440.87
Upside: +30.42%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $762.73
Upside: +44.22%
Oct 30, 2024
Downgrades: Underperform
Price Target: $120 → $20
Current: $8.69
Upside: +130.15%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $9.23
Upside: +235.86%
Aug 19, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $0.37
Upside: +2,568.80%
Jul 31, 2024
Maintains: Buy
Price Target: $150 → $145
Current: $79.06
Upside: +83.41%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $149.79
Upside: +13.49%
Apr 12, 2024
Maintains: Buy
Price Target: $40 → $38
Current: $34.87
Upside: +8.98%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $23.60
Upside: +103.39%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $46.86
Upside: +28.04%
Dec 15, 2023
Downgrades: Neutral
Price Target: $8
Current: $1.17
Upside: +583.76%
Sep 8, 2023
Downgrades: Neutral
Price Target: $23 → $14
Current: $5.23
Upside: +167.69%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $5.44
Upside: +47.19%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $0.50
Upside: +3,296.60%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $23.97
Upside: +87.73%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $1.96
Upside: +1,124.49%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $3.21
Upside: +24.61%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $1.37
Upside: +1,943.80%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.58
Upside: +5,742.93%
May 7, 2021
Upgrades: Buy
Price Target: $56
Current: $4.41
Upside: +1,169.84%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $1.07
Upside: +3,171.03%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $3.37
Upside: +15,478.64%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $1.09
Upside: +3,753.21%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $6.34
Upside: +215.46%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.46
Upside: +4,271.58%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $3.20
Upside: +181.69%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $8.43
Upside: +611.74%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $3.93
Upside: +78.12%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $12.48
Upside: +84.29%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $68.46
Upside: +19.78%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $290.75
Upside: -67.33%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $9.40
Upside: +751.06%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $126.55
Upside: +6.68%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $5.72
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $0.70
Upside: +2,750.63%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $14.46
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $309.70
Upside: -48.98%